Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia

Related articles

06 Sep 2020 : Clinical Research

Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up

Małgorzata Urban-Kowalczyk, Magdalena Kotlicka-Antczak, [...] Dominik Strzelecki, Ewa Rudecka, Janusz Śmigielski - Show fewer authors

DOI: 10.12659/MSM.924307

10 Feb 2020 : Clinical Research

Peripheral Blood Leukocyte RNA-Seq Identifies a Set of Genes Related to Abnormal Psychomotor Behavior Characteristics in Patients with Schizophrenia

Yunqiao Zhang, Xu You, [...] Siwu Li, Qing Long, Yun Zhu, Zhaowei Teng, Yong Zeng - Show fewer authors

DOI: 10.12659/MSM.922426

10 Jun 2019 : Laboratory Research

Regulatory Role of lncRNA NONHSAT089447 in the Dopamine Signaling Pathway in Schizophrenic Patients

Shengdong Chen, Xiaoli Zhu, [...] Wei Niu, Gaofeng Yao, Lingming Kong, Mingjun He, Chunxia Chen, Zhengbin Lu, Xuelian Cui, Liyi Zhang - Show fewer authors

DOI: 10.12659/MSM.915684

09 Oct 2017 : Animal Research

Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice

Hongxia Liu, Jinguo Zhai, [...] Bin Wang, Maosheng Fang - Show fewer authors

DOI: 10.12659/MSM.903842

21 Sep 2016 : Clinical Research

Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients

Shengdong Chen, Xinyang Sun, [...] Wei Niu, Lingming Kong, Mingjun He, Wanshuai Li, Aifang Zhong, Jim Lu, Liyi Zhang - Show fewer authors

DOI: 10.12659/MSM.896927

21 Aug 2014 : Clinical Research

Suicidal Behavior in Schizophrenia may be Related to Low Lipid Levels

Babajohn Ainiyet, Janusz K. Rybakowski

DOI: 10.12659/MSM.890884

01 Jun 2012

Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia

Agata Szulc, Beata Galińska-Skok, [...] Eugeniusz Tarasów, Beata Konarzewska, Napoleon Waszkiewicz, Rafał Hykiel, Jerzy Walecki - Show fewer authors

DOI: 10.12659/MSM.882909

22 Dec 2011

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs

Katarzyna Kucharska-Pietura, Aneta Tylec, [...] Andrzej Czernikiewicz, Ann Mortimer - Show fewer authors

DOI: 10.12659/MSM.882202

28 Jun 2012

Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: Potential involvement of endogenous morphine in the pathophysiology of schizophrenia

George B. Stefano, Milena Králíčková, [...] Radek Ptacek, Hana Kuzelova, Tobias Esch, Richard M. Kream - Show fewer authors

DOI: 10.12659/MSM.883192

08 Dec 2015 : Animal Research

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model

Sema Inanir, Umit Sertan Copoglu, [...] Hanifi Kokacya, Recep Dokuyucu, Oytun Erbas, Ahmet Inanir - Show fewer authors

DOI: 10.12659/MSM.895505

24 Dec 2014 : Clinical Research

When does Subliminal Affective Image Priming Influence the Ability of Schizophrenic Patients to Perceive Face Emotions?

Lucia Maria Vaina, Kunjan D. Rana, [...] Ionela Cotos, Chen Li-Yang, Melissa A. Huang, Delia Podea - Show fewer authors

DOI: 10.12659/MSM.893118

03 Feb 2014 : Original article

Evaluation of the Trail Making Test and interval timing as measures of cognition in healthy adults: Comparisons by age, education, and gender

Włodzimierz Płotek, Wojciech Łyskawa, [...] Anna Kluzik, Małgorzata Grześkowiak, Roland Podlewski, Zbigniew Żaba, Leon Drobnik - Show fewer authors

DOI: 10.12659/MSM.889776

30 Aug 2012

Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis

Krzysztof Krysta, Irena Krupka-Matuszczyk, [...] Małgorzata Janas-Kozik, Małgorzata Stachowicz, Jan Szymszal, Janusz K. Rybakowski - Show fewer authors

DOI: 10.12659/MSM.883355

24 Apr 2011

Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia

Andrzej Cechnicki, Igor Hanuszkiewicz, [...] Romuald Polczyk, Anna Bielańska - Show fewer authors

DOI: 10.12659/MSM.881768

06 Feb 2016 : Clinical Research

DNA Methylation of BDNF Gene in Schizophrenia

Ümit Sertan Çöpoğlu, Mehri Igci, [...] Esra Bozgeyik, M. Hanifi Kokaçya, Yusuf Ziya İğci, Recep Dokuyucu, Mustafa Ari, Haluk A. Savaş - Show fewer authors

DOI: 10.12659/MSM.895896

13 Jun 2018 : Clinical Research

Changes in Gray Matter Density, Regional Homogeneity, and Functional Connectivity in Methamphetamine-Associated Psychosis: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study

Shengyu Zhang, Qiang Hu, [...] Tao Tang, Chao Liu, Chengchong Li, Yin-Yin Zang, Wei-Xiong Cai - Show fewer authors

DOI: 10.12659/MSM.905354

01 Aug 2008

Neuropsychological diagnosis and treatment after closed-head injury in a patient with a psychiatric history of schizophrenia

Maria Pąchalska, Bożena Grochmal-Bach, [...] Bruce Duncan MacQueen, Magdalena Wilk, Małgorzata Lipowska, Izabela Herman-Sucharska - Show fewer authors

01 Jul 2008

Helicobacter pylori: a role in schizophrenia?

Yusuf Yilmaz, Cuma Bulent Gul, [...] Mahmut Arabul, Mehmet Ali Eren - Show fewer authors

29 May 2008

Schizophrenia and viral infection during neurodevelopment: a pathogenesis model?

Valeriu Fruntes, Frederic Limosin

01 Oct 2007

Neural complexity, dissociation and schizophrenia

Petr Bob, Marek Susta, [...] Jan Chladek, Katerina Glaslova, Peter Fedor-Freybergh - Show fewer authors

01 Feb 2006

Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to Olanzapine or Olanzapine-related weight gain in persons with schizophrenia.

Jeffrey R. Bishop, Vicki L. Ellingrod, [...] Jessica Moline, Del Miller - Show fewer authors

10 Apr 2006

Magnetization transfer imaging in chronic schizophrenia.

Aneta Antosik-Biernacka, Henrik Peuskens, [...] Marc De Hert, Josef Peuskens, Stefan Sunaert, Paul Van Hecke, Bożena Goraj - Show fewer authors

01 Sep 2005

Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.

Shih-Jen Tsai,

01 Dec 2004

Can perinatal supplementation of long-chain polyunsaturated fatty acids prevents schizophrenia in adult life?

Undurti N. Das,

01 May 2004

Olanzapine in the treatment of agitation in hospitalized patients with schizophrenia and schizoaffective and schizofreniform disorders

Jacek Turczyński, Leszek Bidzan, [...] Ewa Staszewska-Małys - Show fewer authors

02 Feb 2004

Glutamatergic system dysfunction in schizophrenia. A proton magnetic resonance spectroscopy (1H MRS) study

Agata Szulc, Beata Galińska, [...] Eugeniusz Tarasów, Bożena Kubas, Andrzej Czernikiewicz, Wojciech Dzienis, Jerzy Walecki - Show fewer authors